PranaX Corporation Closes $17 million Oversubscribed Series A Round
PR Newswire —
HOUSTON, Jan. 29, 2026 /PRNewswire/ -- PranaX Corporation, a leading biotechnology company focused on regenerative biologics, today announced the closing of its oversubscribed $17 million Series A financing. The Series A round was led by family offices, trusts, and individual investors, a...